GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Spectral Medical Inc (TSX:EDT) » Definitions » Debt-to-Equity

Spectral Medical (TSX:EDT) Debt-to-Equity : -0.43 (As of Sep. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Spectral Medical Debt-to-Equity?

Spectral Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was C$13.02 Mil. Spectral Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was C$0.40 Mil. Spectral Medical's Total Stockholders Equity for the quarter that ended in Sep. 2024 was C$-31.28 Mil. Spectral Medical's debt to equity for the quarter that ended in Sep. 2024 was -0.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Spectral Medical's Debt-to-Equity or its related term are showing as below:

TSX:EDT' s Debt-to-Equity Range Over the Past 10 Years
Min: -2.83   Med: -0.43   Max: 2.6
Current: -0.43

During the past 13 years, the highest Debt-to-Equity Ratio of Spectral Medical was 2.60. The lowest was -2.83. And the median was -0.43.

TSX:EDT's Debt-to-Equity is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 0.275 vs TSX:EDT: -0.43

Spectral Medical Debt-to-Equity Historical Data

The historical data trend for Spectral Medical's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spectral Medical Debt-to-Equity Chart

Spectral Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 -1.00 0.14 -1.60 -0.52

Spectral Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.21 -0.52 -0.46 -0.57 -0.43

Competitive Comparison of Spectral Medical's Debt-to-Equity

For the Diagnostics & Research subindustry, Spectral Medical's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spectral Medical's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Spectral Medical's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Spectral Medical's Debt-to-Equity falls into.



Spectral Medical Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Spectral Medical's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Spectral Medical's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spectral Medical  (TSX:EDT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Spectral Medical Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Spectral Medical's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Spectral Medical Business Description

Traded in Other Exchanges
Address
135 The West Mall, Unit 2, Finance, Toronto, ON, CAN, M9C 1C2
Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.
Executives
Paul M. Walker Director
John Ernest Nosenzo Director
Chris Seto Senior Officer
William Charles Stevens Director
Kevin Arnold Giese Director
Gualtiero Piero Guido Maria Guadagni Senior Officer
Debra-anne Foster Deemed Insider - 6 Months before becoming Insider
Anthony Phillip Bihl Director

Spectral Medical Headlines